Amy House has over 20 year of experience in health care and the life sciences. Most recently, she was Chief of Staff to the Chief Medical Officer at Gyroscope Therapeutics, a clinical-stage gene therapy company acquired by Novartis last year for $800M. She also served as the Gyroscope Integration and Transition Lead following the aquisition. Previously, Amy developed and managed strategic alliances for faculty with industry partners and investors at Johns Hopkins Technology Ventures. She also has extensive management consulting experience with health care organizations and life sciences companies, including work with Sage Growth Partners where she partnered with early and growth-stage companies to assess market opportunities and develop Go-to-Market strategies. Amy has an MBA from Duke University and a BA in Public Health from Johns Hopkins University.